Search Results

HOME > SEARCH > SEARCH RESULTS

Refine by Audience:

Your search for pilot research returned 129 results.

Selected filters: Patients

International

Displaying 71 to 80 of 129 records
Sort by: Page: << Prev 5… 6… 7… 8… 9… 10… 11… Next >>

Julie Sutcliffe, PhD, Receives SNMMI Mars Shot Fund Award – Jun 7, 2023
SNMMI is excited to announce that Julie Sutcliffe, PhD, has been selected as the recipient of a $500,000 grant from the 2023 Mars Shot Fund.
Randy Yeh, MD, Receives SNMMI Mars Shot Fund Award – Jun 7, 2023
SNMMI is excited to announce that Randy Yeh, MD, has been selected as the recipient of a $500,000 grant from the 2023 Mars Shot Research Fund.
Ellison, Scott and Sanford Receive SNMMI Mars Shot Fund Award – Jun 7, 2023
SNMMI is excited to announce Paul Ellison, PhD, Peter J. H. Scott, PhD, and Melanie S. Sanford, PhD, have been selected as the recipients of a $500,000 grant from the 2023 Mars Shot Fund.
Amino Acid PET Successfully Differentiates Recurrent Brain Metastases, Reducing Invasive Procedures and Overtreatment – May 12, 2023
A new meta-analysis indicates that amino acid PET can accurately differentiate recurrent or progressive brain metastases from treatment-related changes, potentially reducing overtreatment, according to research published in May JNM.
New Research: FAPI PET Imaging Superior for Diagnosing Multiple Types of Cancer, with Potential for Targeted Treatment – May 1, 2023
Two articles in the May issue of JNM illustrate the promise of the novel FAPI radiotracer. Results from the largest study of patients undergoing 68Ga-FAPI PET demonstrate the superiority of 68Ga-FAPI over standard 18F-FDG PET in evaluating multiple types of cancer. In a separate study, a newly designed FAPI-targeted treatment was found to suppress tumor growth in several common cancers in a preclinical setting. These advances have strong potential to provide more precise staging and management for cancer patients.
Newly Developed PSG Score Improves Patient Selection for PSMA Radiopharmaceutical Therapy – Apr 19, 2023
International, multicenter testing demonstrated the effectiveness of a newly established PSMA PET scoring system that can successfully predict whether metastatic castration-resistant prostate cancer patients will respond to treatment with Lu-177 PSMA therapy. The research was published online in JNM.
JNM Publishes Appropriate Use Criteria for Lymphoscintigraphy in Sentinel Node Mapping and Lymphedema/Lipedema – Apr 14, 2023
SNMMI and 10 other professional societies have issued appropriate use criteria for lymphoscintigraphy in sentinel node mapping and lymphedema/lipedema. The criteria are summarized in the April issue of JNM.
New Nuclear Medicine Therapy Cures Human Non-Hodgkin Lymphoma in Preclinical Model – Apr 11, 2023
A single dose of the radioimmunotherapy can cure human non-Hodgkin lymphoma in an animal model, according to research published in the April issue of The Journal of Nuclear Medicine.
Blood-Based Biomarkers Accurately Predict Neuroendocrine Tumor Response to Radiopharmaceutical Therapy – Apr 6, 2023
A simple blood draw can provide physicians with valuable information about whether PRRT is likely to be effective in a patient with neuroendocrine canceropening new possibilities for tailoring radiopharmaceutical treatment to patients. The research is published in the April issue of JNM.
Molecular Imaging Offers Insight Into Chemo-Brain – Mar 28, 2023
A new literature review sheds light on how nuclear medicine brain imaging can help evaluate the biological changes that cause chemotherapy-related cognitive impairment (CRCI), commonly known as chemo-brain. This informationpublished ahead-of-print in JNMcan help patients better understand the changes in their cognitive status during and after treatment.

Displaying 71 to 80 of 129 records
Page: << Prev 5… 6… 7… 8… 9… 10… 11… Next >>